IL59628A - 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them - Google Patents

4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them

Info

Publication number
IL59628A
IL59628A IL59628A IL5962880A IL59628A IL 59628 A IL59628 A IL 59628A IL 59628 A IL59628 A IL 59628A IL 5962880 A IL5962880 A IL 5962880A IL 59628 A IL59628 A IL 59628A
Authority
IL
Israel
Prior art keywords
esters
salts
amino
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL59628A
Other languages
English (en)
Other versions
IL59628A0 (en
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of IL59628A0 publication Critical patent/IL59628A0/xx
Publication of IL59628A publication Critical patent/IL59628A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL59628A 1979-03-26 1980-03-14 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them IL59628A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2398179A 1979-03-26 1979-03-26
US06/127,153 US4343804A (en) 1979-03-26 1980-03-04 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds

Publications (2)

Publication Number Publication Date
IL59628A0 IL59628A0 (en) 1980-06-30
IL59628A true IL59628A (en) 1983-06-15

Family

ID=26697875

Family Applications (1)

Application Number Title Priority Date Filing Date
IL59628A IL59628A (en) 1979-03-26 1980-03-14 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them

Country Status (31)

Country Link
US (1) US4343804A (en:Method)
JP (1) JPH02117663A (en:Method)
AR (1) AR230268A1 (en:Method)
AT (1) AT372373B (en:Method)
AU (1) AU528388B2 (en:Method)
BR (1) BR8001779A (en:Method)
CA (1) CA1147338A (en:Method)
CH (1) CH644105A5 (en:Method)
DE (1) DE3011490A1 (en:Method)
DK (1) DK156056C (en:Method)
EG (1) EG15009A (en:Method)
ES (1) ES8103048A1 (en:Method)
FI (1) FI77452C (en:Method)
FR (1) FR2452485B1 (en:Method)
GB (1) GB2047244B (en:Method)
GR (1) GR68006B (en:Method)
HK (1) HK67983A (en:Method)
IE (1) IE49577B1 (en:Method)
IL (1) IL59628A (en:Method)
IN (1) IN151446B (en:Method)
IT (1) IT1133079B (en:Method)
MX (1) MX6264E (en:Method)
NL (1) NL8001752A (en:Method)
NO (1) NO153927C (en:Method)
NZ (1) NZ193252A (en:Method)
PH (1) PH16416A (en:Method)
PL (1) PL125030B1 (en:Method)
PT (1) PT71008B (en:Method)
SE (1) SE435837B (en:Method)
SG (1) SG33683G (en:Method)
YU (1) YU41702B (en:Method)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610981D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Quinoline amides
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5432182A (en) * 1989-02-23 1995-07-11 Smithkline Beecham Intercredit B.V. Compounds substituted quinoline derivatives
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
US5362743A (en) * 1993-03-09 1994-11-08 Pfizer Inc. Aminoquinoline derivatives
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
JP3980052B2 (ja) * 1993-08-10 2007-09-19 ジェイムズ・ブラック・ファウンデーション・リミテッド ガストリンとｃｃｋレセプタリガンド
US5650415A (en) * 1995-06-07 1997-07-22 Sugen, Inc. Quinoline compounds
KR0169813B1 (ko) * 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
US5760041A (en) * 1996-02-05 1998-06-02 American Cyanamid Company 4-aminoquinazoline EGFR Inhibitors
US6875769B2 (en) * 1996-05-23 2005-04-05 Pfizer Inc. Substituted6,6-hetero-bicyclicderivatives
US5929080A (en) * 1997-05-06 1999-07-27 American Cyanamid Company Method of treating polycystic kidney disease
US6251912B1 (en) 1997-08-01 2001-06-26 American Cyanamid Company Substituted quinazoline derivatives
US6323209B1 (en) 1997-11-06 2001-11-27 American Cyanamid Company Method of treating or inhibiting colonic polyps
ES2457396T3 (es) 1998-09-29 2014-04-25 Wyeth Holdings Llc 3-Cianoquinolinas sustituidas como inhibidores de las proteínas tirosina quinasas
NZ519380A (en) * 1999-12-28 2004-10-29 Eisai Co Ltd Heterocyclic compounds having sulfonamide groups
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6576644B2 (en) * 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ATE374766T1 (de) 2003-01-14 2007-10-15 Arena Pharm Inc 1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie
MXPA04008070A (es) 2003-03-10 2004-11-26 Altana Pharma Ag Novedoso proceso para la preparacion de roflumilasto.
NZ544200A (en) * 2003-07-14 2009-07-31 Arena Pharm Inc Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ES2421916T3 (es) * 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
WO2011022216A1 (en) * 2009-08-17 2011-02-24 High Point Pharmaceuticals, Llc Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
SG10201500639TA (en) 2010-01-27 2015-03-30 Arena Pharm Inc Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
BR112013008100A2 (pt) 2010-09-22 2016-08-09 Arena Pharm Inc "moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles."
HUE069888T2 (hu) 2015-01-06 2025-04-28 Arena Pharm Inc Vegyületek az S1P1 receptorral összefüggõ állapotok kezelésében történõ alkalmazásra
KR102883123B1 (ko) 2015-06-22 2025-11-10 아레나 파마슈티칼스, 인크. Ｓ1ｐ1 수용체-관련 장애에서의 사용을 위한 (ｒ)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[ｂ]인돌-3-일)아세트산 (화합물 1)의 결정성 ｌ-아르기닌 염
ES2884073T3 (es) * 2016-11-11 2021-12-10 Bayer Animal Health Gmbh Nuevos derivados antihelmínticos de quinolina-3-carboxamida
MA47504A (fr) 2017-02-16 2019-12-25 Arena Pharm Inc Composés et méthodes de traitement de l'angiocholite biliaire primitive
WO2019084271A1 (en) * 2017-10-25 2019-05-02 Children's Medical Center Corporation PAPD5 INHIBITORS AND METHODS OF USE
EP3790874B1 (en) 2018-05-09 2023-03-15 Bayer Animal Health GmbH Anthelmintic quinoline derivatives
CN112601516A (zh) 2018-06-06 2021-04-02 艾尼纳制药公司 治疗与s1p1受体相关的病况的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
JPS4838712A (en:Method) * 1971-09-18 1973-06-07

Also Published As

Publication number Publication date
IE800605L (en) 1980-09-26
FI77452B (fi) 1988-11-30
FR2452485A1 (fr) 1980-10-24
NL8001752A (nl) 1980-09-30
FI77452C (fi) 1989-03-10
AU528388B2 (en) 1983-04-28
IT8067465A0 (it) 1980-03-26
YU41702B (en) 1987-12-31
MX6264E (es) 1985-02-19
AU5684880A (en) 1980-10-02
DK156056C (da) 1989-11-06
YU84480A (en) 1983-10-31
JPH02117663A (ja) 1990-05-02
SE435837B (sv) 1984-10-22
US4343804A (en) 1982-08-10
IT1133079B (it) 1986-07-09
SG33683G (en) 1985-03-29
CA1147338A (en) 1983-05-31
PL222993A1 (en:Method) 1981-01-30
IE49577B1 (en) 1985-10-30
PL125030B1 (en) 1983-03-31
PT71008B (en) 1981-06-25
AT372373B (de) 1983-09-26
SE8002292L (sv) 1980-09-27
GR68006B (en:Method) 1981-10-26
DK128380A (da) 1980-09-27
ES489887A0 (es) 1981-02-16
ES8103048A1 (es) 1981-02-16
NO800858L (no) 1980-09-29
EG15009A (en) 1985-03-31
BR8001779A (pt) 1980-11-18
CH644105A5 (fr) 1984-07-13
GB2047244B (en) 1983-02-23
IN151446B (en:Method) 1983-04-23
GB2047244A (en) 1980-11-26
FR2452485B1 (fr) 1986-09-12
NO153927B (no) 1986-03-10
ATA156480A (de) 1983-02-15
DE3011490A1 (de) 1981-03-12
NO153927C (no) 1986-06-18
IL59628A0 (en) 1980-06-30
AR230268A1 (es) 1984-03-01
DE3011490C2 (en:Method) 1988-12-22
DK156056B (da) 1989-06-19
NZ193252A (en) 1984-04-27
PH16416A (en) 1983-09-29
PT71008A (en) 1980-04-01
HK67983A (en) 1983-12-23
FI800910A7 (fi) 1980-09-27

Similar Documents

Publication Publication Date Title
IL59628A0 (en) 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them
IL60422A (en) Formylhydroxyphenoxy pentanoic and methylbenzoic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them
IL56991A0 (en) 4-halo-3-oxoandrost-4-ene-17 -thiocarboxylic acid esters their preparation and pharmaceutical compositions containing them
IL64185A0 (en) 1-carboxy-azaalkanoylindoline-2-carboxylic acids and ester and amide derivatives thereof,their manufacture and pharmaceutical compositions containing them
IL78528A0 (en) Difluoro-naphthyridine-and trifluoro-quinoline-carboxylic acids and esters and salts thereof and pharmaceutical compositions containing them
NZ189296A (en) N-substituted-omega-aminoalkanoyl-omega-aminoalkanoic acids and pharmaceutical compositions
DE3064453D1 (en) Isoquinoline acetic acids and pharmaceutical compositions thereof
NZ190842A (en) 4-substituted-thiazole-2-oxamic acids and esters and pharmaceutical compositions
ZA822933B (en) Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation
IL61210A0 (en) 3-benzoyl-2-nitrophenylacetic acids and metal salts, amides and esters thereof and pharmaceutical compositions containing them
GB2057427B (en) Oxoimidazolinealkanoic acids and their salts and esters their preparation and pharmaceutical compositions containing them
NZ190521A (en) Phenylamino-thiophenacetic acids and pharmaceutical compositions
IL52820A0 (en) New acylated heterocyclylcarboxylic acids and salts thereof their preparation and pharmaceutical compositions containing them
NZ194784A (en) 7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
IL55152A0 (en) 7-acylamido-3-cephem-4-carboxylic acids and esters and salts thereof,their preparation and pharmaceutical compositions containing them
NZ194241A (en) 7b-aminothiadiazolylacetamido-3-cephem-4 carboxylic acid derivatives and pharmaceutical compositions
NZ185511A (en) 2-(2-amidoethylidene)-clavam-3-carboxylic acids salts and esters and pharmaceutical compositions
DE2967551D1 (en) 5(6)-(2-amino-5-thiazoloyl)benzimidazole-2-carbamic acid esters and their salts, their preparation and use, and pharmaceutical compositions containing them
JPS5692843A (en) Nnsubstituted alphaaamino acids*their manufacture and medicinal composition containing them
PH14995A (en) Oxaminic acids and esters thereof and pharmaceutical compositions containing these compounds
NZ187474A (en) 4-heterocyclyl-piperazine-i-carbodithioic acids and salts and pharmaceutical compositions thereof
NZ194122A (en) Acylaminobenzoic acid derivatives and pharmaceutical compositions
NZ189295A (en) N-substituted-acyl-aminoalkanoic acids and pharmaceutical compositions
IL52952A0 (en) New hydroxymethyl-pyridine esters their preparation and pharmaceutical compositions containing them
IL58154A0 (en) 1-methyl-4-piperidinol esters their preparation and pharmaceutical compositions containing them